Inventor
ADAMS RALPH
GB40 patents
⚠️ This page may combine multiple inventors who share the name “ADAMS RALPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UCB PHARMA SA
10 patentsUS8784823B2Jul 22, 2014
Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof
UCB PHARMA SA38 citations96
US9040048B2May 26, 2015
Antibody molecules having specificity for human OX40
UCB PHARMA SA19 citations92
US10421816B2Sep 24, 2019
Multivalent antibodies
UCB PHARMA SA2 citations72
US9034600B2May 19, 2015
DNA encoding antibody molecules which bind IL-17A and IL-17F
UCB PHARMA SA1 citations63
US8617847B2Dec 31, 2013
Nucleic acids encoding antibody molecules which bind IL-17A and IL-17F
UCB PHARMA SA1 citations63
US8865167B2Oct 21, 2014
Neutralising antibody molecules having specificity for human IL-17
UCB PHARMA SA2 citations62
US9631015B2Apr 25, 2017
Methods for treating IL-6 mediated diseases with antibody molecules specific for IL-6
UCB PHARMA SA1 citations61
US9321840B2Apr 26, 2016
Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof
UCB PHARMA SA2 citations61
US9096668B2Aug 4, 2015
Methods for making antibody molecules having specificity for human IL-6
UCB PHARMA SA2 citations61
US12091450B2Sep 17, 2024
Antibodies of the class IGG4
UCB PHARMA SA0 citations59
UCB Biopharma SRL
8 patentsUS11261242B2Mar 1, 2022
Anti-alpha-synuclein antibodies
UCB Biopharma SRL3 citations71
US11999772B2Jun 4, 2024
Antibodies comprising a polypeptide inserted in framework 3 region
UCB Biopharma SRL0 citations62
US11919950B2Mar 5, 2024
Expression vector encoding antibody molecule which binds IL-17A and IL-17F
UCB Biopharma SRL0 citations62
US12545720B2Feb 10, 2026
Anti-alpha-synuclein antibodies
UCB Biopharma SRL0 citations61
US11091542B2Aug 17, 2021
Antibody molecules which bind TNF alpha
UCB Biopharma SRL0 citations61
US12327614B2Jun 10, 2025
Multi-domain proteins with increased native state colloidal stability
UCB Biopharma SRL0 citations55
US12054559B2Aug 6, 2024
Anti-IgE antibodies
UCB Biopharma SRL0 citations54
US11214627B2Jan 4, 2022
Anti-IgE antibodies
UCB Biopharma SRL0 citations54
UCB BIOPHARMA SPRL
7 patentsUS9873735B2Jan 23, 2018
Method of treatment with antibodies having specificity for human OX40
UCB BIOPHARMA SPRL12 citations83
US9803004B2Oct 31, 2017
Albumin binding antibodies and binding fragments thereof
UCB BIOPHARMA SPRL10 citations83
US10308723B2Jun 4, 2019
Method of treating inflammation by administering antibody molecules which bind IL-17A and IL-17F
UCB BIOPHARMA SPRL1 citations73
US9988446B2Jun 5, 2018
Methods of treatment using antibodies which bind IL-17A and IL-17F
UCB BIOPHARMA SPRL2 citations73
US10023631B2Jul 17, 2018
Albumin binding antibodies and binding fragments thereof
UCB BIOPHARMA SPRL3 citations72
US9890219B2Feb 13, 2018
Methods of treating an IL-17A mediated pathological condition
UCB BIOPHARMA SPRL1 citations63
US11466076B2Oct 11, 2022
Binding domain or antibody specific to a human serum albumin (HSA)
UCB BIOPHARMA SPRL0 citations62
ADAMS RALPH
6 patentsUS8303953B2Nov 6, 2012
Antibody molecules which bind IL-17A and IL-17F
ADAMS RALPH18 citations92
US8231875B2Jul 31, 2012
Neutralising antibody molecules having specificity for human IL-17
ADAMS RALPH15 citations91
US8580265B2Nov 12, 2013
Antibody molecules which bind IL-17A and IL-17F
ADAMS RALPH16 citations88
US8329431B2Dec 11, 2012
Nucleic acid molecules encoding neutralising antibodies having specificity for human IL-17
ADAMS RALPH6 citations83
US10407513B2Sep 10, 2019
Biological products
ADAMS RALPH3 citations66
US9249232B2Feb 2, 2016
Framework selection
ADAMS RALPH1 citations51
HARVARD COLLEGE
3 patentsUS12247068B2Mar 11, 2025
Anti-AP2 antibodies and antigen binding agents to treat metabolic disorders
HARVARD COLLEGE1 citations69
US10160798B2Dec 25, 2018
Anti-aP2 antibodies and antigen binding agents to treat metabolic disorders
HARVARD COLLEGE4 citations68
US11014979B2May 25, 2021
Anti-AP2 antibodies and antigen binding agents to treat metabolic disorders
HARVARD COLLEGE4 citations67